Andrew Franklin, Chief Financial Officer
Andrew joined the board of Alliance on the 28 September 2015 following his appointment as Chief Financial Officer. From 2010 to 2012, Andrew was Finance Director and Company Secretary of Genzyme Therapeutics Ltd. Prior to that, he gained 12 years’ pharmaceutical experience with Wyeth in a variety of senior financial positions. Andrew joins Alliance from Panasonic Europe Ltd, where he was General Manager, European Tax and Accounting. He qualified as a Chartered Accountant with Arthur Andersen in 1992 having graduated with an honours degree in Civil Engineering from the University of Wales, Cardiff in 1988.